Table 1:

data of patients classified by diagnosis

DiagnosisFemale/maleAge
(years mean; min–max)
JSLE (n = 8)6/212 (7–17)
JDM (n = 9)2/79 (4–15)
Interferonopathy (n = 7)5/210 (3–15)
 COPA (n = 3)3/08 (3–15)
 AGS (n = 2)0/28 (5–10)
 SAVI (n = 2)2/015 (14–15)
PF (n = 7)3/45 (2–8)
JIA (n = 8)6/27 (1–18)
DiagnosisFemale/maleAge
(years mean; min–max)
JSLE (n = 8)6/212 (7–17)
JDM (n = 9)2/79 (4–15)
Interferonopathy (n = 7)5/210 (3–15)
 COPA (n = 3)3/08 (3–15)
 AGS (n = 2)0/28 (5–10)
 SAVI (n = 2)2/015 (14–15)
PF (n = 7)3/45 (2–8)
JIA (n = 8)6/27 (1–18)

Abbreviations: AGS: Aicardi–Goutières syndrome; COPA: coatomer protein complex subunit alpha; JDM: juvenile dermatomyositis; JIA: juvenile idiopathic arthritis; JSLE: juvenile systemic lupus erythematosus; PF: periodic fevers; SAVI: STING (stimulator of interferon genes) associated vasculopathy with onset in infancy.

Table 1:

data of patients classified by diagnosis

DiagnosisFemale/maleAge
(years mean; min–max)
JSLE (n = 8)6/212 (7–17)
JDM (n = 9)2/79 (4–15)
Interferonopathy (n = 7)5/210 (3–15)
 COPA (n = 3)3/08 (3–15)
 AGS (n = 2)0/28 (5–10)
 SAVI (n = 2)2/015 (14–15)
PF (n = 7)3/45 (2–8)
JIA (n = 8)6/27 (1–18)
DiagnosisFemale/maleAge
(years mean; min–max)
JSLE (n = 8)6/212 (7–17)
JDM (n = 9)2/79 (4–15)
Interferonopathy (n = 7)5/210 (3–15)
 COPA (n = 3)3/08 (3–15)
 AGS (n = 2)0/28 (5–10)
 SAVI (n = 2)2/015 (14–15)
PF (n = 7)3/45 (2–8)
JIA (n = 8)6/27 (1–18)

Abbreviations: AGS: Aicardi–Goutières syndrome; COPA: coatomer protein complex subunit alpha; JDM: juvenile dermatomyositis; JIA: juvenile idiopathic arthritis; JSLE: juvenile systemic lupus erythematosus; PF: periodic fevers; SAVI: STING (stimulator of interferon genes) associated vasculopathy with onset in infancy.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close